Related Experiment Videos
Aryl-s-tetrazines with antiinflammatory activity
Journal of Medicinal Chemistry
|December 11, 1976
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery.
Clinics and research in hepatology and gastroenterology·2026
Comparison between moyamoya disease and moyamoya syndrome in Israel.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2024
Effects of tumor type on outcomes in patients with large vessel occlusion stroke and cancer.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2023
Covid-19 associated free hanging clots in acute symptomatic carotid stenosis.
Journal of the neurological sciences·2022
A synopsis of global frontiers in fertility preservation.
Journal of assisted reproduction and genetics·2022
Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation.
Journal of medicinal chemistry·2026
Targeting RNA-Binding Oncofetal Protein IGF2BP3: Discovery of Potent and Selective Inhibitors.
Journal of medicinal chemistry·2026
Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation.
Journal of medicinal chemistry·2026
Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus <i>Penicillium herquei</i>.
Journal of Asian natural products research·2026
The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.
Frontiers in behavioral neuroscience·2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.
Endocrine, metabolic & immune disorders drug targets·2026